• Developing an mRNA Therapy for DMD with Elixirgen Therapeutics' Aki Ko

  • Jun 6 2024
  • Duración: 15 m
  • Podcast

Developing an mRNA Therapy for DMD with Elixirgen Therapeutics' Aki Ko  Por  arte de portada

Developing an mRNA Therapy for DMD with Elixirgen Therapeutics' Aki Ko

  • Resumen

  • We love to hear from our listeners. Send us a message.

    Elixirgen Therapeutics' Aki Ko joins Erin Harris to detail the company's Bobcat mRNA therapeutic and how it differs from traditional exon-skipping drugs and AAV-microdystrophin in treating DMD. Regarding delivery, Ko explains the advantage of the mRNA approach over the AAV approach.

    Más Menos
activate_primeday_promo_in_buybox_DT

Lo que los oyentes dicen sobre Developing an mRNA Therapy for DMD with Elixirgen Therapeutics' Aki Ko

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.